World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
71
Citations
19013
World Ranking
19983
National Ranking
9954

Janet L. Davis publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Janet L. Davis sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 331 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Janet L. Davis D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Janet L. Davis sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 71 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Janet L. Davis is affiliated with the University of Miami in the United States and has a significant body of work primarily in the field of Medicine, with a strong emphasis on Ophthalmology. Their research spans 139 publications in Medicine, including 83 in Ophthalmology, supplemented by studies in Molecular Biology, Radiology, Nuclear Medicine and Imaging, Rheumatology, and Epidemiology.

Their scholarly output includes contributions to several major publication venues, notably the American Journal of Ophthalmology with 10 publications, American Journal of Ophthalmology Case Reports with 7, Ophthalmology and Ophthalmology Retina each with 4, and Ocular Immunology and Inflammation with 4.

Key research topics covered by Janet L. Davis include:

  • Ocular Diseases and Behçet's Syndrome
  • Retinal and Optic Conditions
  • Retinal Diseases and Treatments
  • Retinal Development and Disorders
  • Vasculitis and related conditions
  • Ocular Infections and Treatments
  • Intraocular Surgery and Lenses

Frequently collaborating with other researchers, Janet L. Davis has strong co-authorship ties with Byron L. Lam, Marc D. de Smet, Douglas A. Jabs, Justine R. Smith, and Rupesh Agrawal.

Selected recent papers by Janet L. Davis include:

  • Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR, 2020, Nature Medicine
  • Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1, 2020, Ophthalmology
  • Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2, 2020, Ophthalmology
  • Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations, 2023, JAMA Ophthalmology
  • Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee, 2023, Journal of VitreoRetinal Diseases

Best Publications

  • Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies

    Steven D. Schwartz;Carl D. Regillo;Byron L. Lam;Dean Eliott

  • An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.

    Anne E. Fung;Geeta A. Lalwani;Philip J. Rosenfeld;Sander R. Dubovy

  • A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.

    Geeta A. Lalwani;Philip J. Rosenfeld;Anne E. Fung;Sander R. Dubovy

  • Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Ryan M. Rich;Philip J. Rosenfeld;Carmen A. Puliafito;Sander R. Dubovy

  • Primary Vitreoretinal Lymphoma: A Report from an International Primary Central Nervous System Lymphoma Collaborative Group Symposium

    Chi Chao Chan;James L. Rubenstein;Sarah E. Coupland;Janet L. Davis

  • Ocular complications of pediatric uveitis.

    Krista D. Rosenberg;William J. Feuer;Janet L. Davis

  • Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes

    Vivian Schiedler;Ingrid U. Scott;Harry W. Flynn;Janet L. Davis

  • Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis.

    Thomas F Essman;Harry W Flynn;William E Smiddy;Roy D Brod

  • Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy.

    David A. Palay;Paul Sternberg;Janet Davis;Hilel Lewis

  • Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR

    Jasmina Cehajic-Kapetanovic;Kanmin Xue;Cristina Martinez-Fernandez de la Camara;Anika Nanda

  • Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes.

    Geeta A. Lalwani;Harry W. Flynn;Ingrid U. Scott;Carolyn M. Quinn

  • Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results.

    William J. Feuer;Joyce C. Schiffman;Janet L. Davis;Vittorio Porciatti

  • Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative

    Andrew D. Dick;Andrew D. Dick;Andrew D. Dick;James T. Rosenbaum;Hassan A. Al-Dhibi;Rubens Belfort

  • ENDOPHTHALMITIS AFTER INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTAGONISTS: A Six-Year Experience at a University Referral Center

    Andrew A. Moshfeghi;Philip J. Rosenfeld;Harry W. Flynn;Stephen G. Schwartz

  • Diagnostic testing of vitrectomy specimens.

    Janet L. Davis;Daniel M. Miller;Phillip Ruiz

  • Endogenous Fungal Endophthalmitis: Causative Organisms, Management Strategies, and Visual Acuity Outcomes

    Ahila Lingappan;Charles C. Wykoff;Thomas A. Albini;Darlene Miller

  • Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis.

    Thomas W. Harper;Darlene Miller;Joyce C. Schiffman;Janet L. Davis

  • Idiopathic Retinal Vasculitis, Aneurysms, and Neuro-retinitis

    T. S. Chang;G. W. Aylward;J. L. Davis;W. F. Mieler

  • Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis.

    Janet L. Davis;Ibrahim Taskintuna;William R. Freeman;David V. Weinberg

  • Mutations Conferring Ganciclovir Resistance in a Cohort of Patients with Acquired Immunodeficiency Syndrome and Cytomegalovirus Retinitis

    Douglas A. Jabs;Douglas A. Jabs;Barbara K. Martin;Michael S. Forman;J. P. Dunn

Frequent Co-Authors

Harry W. Flynn
Harry W. Flynn University of Miami
William E. Smiddy
William E. Smiddy University of Miami
William J. Feuer
William J. Feuer University of Miami
Douglas A. Jabs
Douglas A. Jabs Johns Hopkins University School of Medicine
Philip J. Rosenfeld
Philip J. Rosenfeld University of Miami
Robert B. Nussenblatt
Robert B. Nussenblatt National Institutes of Health
Ingrid U. Scott
Ingrid U. Scott Pennsylvania State University
Gary N. Holland
Gary N. Holland University of California, Los Angeles
Carmen A. Puliafito
Carmen A. Puliafito University of Southern California
Manfred Zierhut
Manfred Zierhut University of Tübingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but considering alternative or complementary healthcare paths, there are a variety of online degree and bridge programs available. If you’re aiming for a nursing career but want to avoid lengthy admissions testing, you might explore a nursing school that don't require teas. This option can streamline your entry into the nursing profession.

If you are interested in healthcare leadership, the best online healthcare administration degree programs can prepare you for management roles within hospitals, insurance companies, or medical offices—all from the convenience of online learning.

Registered nurses looking to advance their careers may consider rn to fnp bridge programs. These bridge options help RNs build on their experience to become Family Nurse Practitioners (FNPs) with expanded responsibilities and increased earning potential.

For those with a passion for wellness and nutrition, pursuing nutrition degrees online can open doors to a range of careers, from clinical settings to public health organizations. Exploring these related pathways can help you find a rewarding career in healthcare that matches your interests and educational goals.

Best Scientists Citing Janet L. Davis

Trending Scientists

Recently Published Articles